Trials / Completed
CompletedNCT02889653
The Bleeding With Antithrombotic Therapy Study 2
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,306 (actual)
- Sponsor
- National Cerebral and Cardiovascular Center, Japan · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the incidence and severity of bleeding complications in patients with cerebrovascular and cardiovascular diseases treated with oral antithrombotic therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Any oral antithrombotics (antiplatelets or anticoagulants) |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2020-03-01
- Completion
- 2021-03-01
- First posted
- 2016-09-05
- Last updated
- 2023-11-09
Locations
9 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02889653. Inclusion in this directory is not an endorsement.